Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 252

The DOI matches its Crossref record.

Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit

Open access
Spiezia, Luca, Boscolo, Annalisa, Correale, Christelle, Sella, Nicolò, Pesenti, Elisa, Beghetto, Luca, Campello, Elena, Poletto, Francesco, Cerruti, Lorenzo, Cola, Marco, De Cassai, Alessandro, Pasin, Laura, Eugenio, Serra, Vettor, Roberto, Cattelan, Anna Maria, Simioni, Paolo, Navalesi, Paolo·2020·Thrombosis and Haemostasis

Abstract

Coagulation abnormalities were common findings in critically ill patients affected by coronavirus infection disease (COVID)-19 and often correlated to more severe illness and poor prognosis.[ 1 ] [ 2 ] [ 3 ] We recently used Rotational Thromboelastometry (ROTEM) to describe severe hypercoagulable profiles and high incidence of symptomatic venous thromboembolic (VTE) events in a small group of COVID-19 patients with acute respiratory failure admitted to intensive care unit (ICU).[ 4 ] However, it remains unclear whether COVID-19 patients with mild clinical symptoms, admitted to internal medicine wards (IMWs), present with different coagulation profiles. The primary outcome of this prospective observational study was to investigate the difference in maximum clot firmness (MCF) between IMW and ICU patients, which reflects the extent of hypercoagulability. Secondary outcome was the incidence of symptomatic VTE. The protocol was approved by the local institutional ethical committee and all consecutive patients admitted to ICU (between February 28 and April 7, 2020) and to IMW (between March 27 and April 14, 2020) for acute respiratory failure caused by SARS-CoV-2 infection were considered for enrollment ([ Supplementary Material, Fig. S1 ], online only). Exclusion criteria were: pregnancy, preexisting bleeding or hematological disorders, acquired coagulopathies, < 18 or > 80 years of age, Child's C liver disease, severe chronic kidney disease, active cancer, and ongoing anticoagulant or antiplatelet therapies. The following EXTEM, INTEM, and FIBTEM parameters were measured: clotting time (CT, second); clot formation time (CFT, second); MCF (mm); and ThromboDynamic Index (TDI), the ratio between MCF/(CT + CFT).[ 5 ] A hypercoagulable thromboelastometry profile was defined as at least one of ROTEM assays yielding significantly higher MCF values versus healthy controls.[ 4 ] [ 6 ] Among 89 consecutive eligible patients, 25 were excluded and 64 finally enrolled ([ Supplementary Fig. S1 ], available in the online version). Details on statistical analysis and sample size calculation are reported in [ Supplementary Material S1 ] (available in the online version). No differences in demographic characteristics were observed between ICU and IMW patients ([ Table 1 ]). Sequential Organ Failure Assessment score, incidence of septic shock, and the rate of infection by other respiratory pathogens were significantly higher in ICU patients. Similarly, white blood cells, neutrophils, fibrinogen, C-reactive protein, procalcitonin, ferritin, and fibrinogen levels were significantly higher ([ Table 1 ]). Table 1 Baseline characteristics, laboratory data, respiratory support, and clinical outcomes Variables ICU n = 32 IMW n = 32 p -Value IMV n = 21 Non-IMV n = 43 p -Value Clinical characteristics Age (y) 68 (62–75) 61 (53–71) 0.08 67 (63–72) 62 (52–75) 0.13 Gender (male) 26 (81) 24 (75) 0.76 18 (86) 32 (74) 0.56 BMI 29 (27–32) 29 (24–32) 0.94 29 (27–32) 29 (25–32) 0.40 Onset of symptoms (d) 8 (7–11) 8 (6–10) 0.56 7 (5–9) 8 (7–11) 0.04 Comorbidities 28 (87) 24 (75) 0.09 21 (100) 31 (72) < 0.01 SOFA score 3 (3–6) 2 (1–2) < 0.001 4.5 (3–7) 2 (1–3) < 0.001 Sepsis-3 criteria (septic shock) 9 (28) 0 (0) < 0.01 8 (38) 1 (4) < 0.01 Other respiratory pathogens 9 (28) 1 (3) 0.01 8 (38) 2 (5) < 0.01 ISTH score 1 (0–2) 0 (0–1.8) 0.06 1 (0–2) 0 (0–2) 0.59 SIC score 2 (2–2) 2 (1–2) 0.12 2 (1–2.25) 2 (1.8–2) 0.09 PaO 2 /FiO 2 134 (121–203) 293 (186–354) < 0.001 138 (127–220) 226 (135–310) 0.02 Laboratory data WBCs (×10 9 /L) 8.3 (6.0–10.4) 6.7 (4.8–8.0) 0.02 8.4 (6.1–10.9) 6.8 (4.9–8.4) 0.06 Neutrophils (×10 9 /L) 7.4 (4.7–9.2) 4.5 (2.8–6.6) < 0.001 7.6 (5.2–9.8) 4.7 (2.9–6.6) < 0.001 Lymphocytes (×10 9 /L) 0.6 (0.4–0.9) 1.2 (0.7–1.4) 0.33 0.5 (0.4–0.8) 1.1 (0.8–1.4) 0.77 Hemoglobin (g/dL) 12 (11–13) 13 (11–14) 0.19 12.3 (10.8–13.3) 12.5 (11.3–13.9) 0.49 Platelet count (×10 9 /L) 283 (194–336) 234 (197–290) 0.13 225 (156–255) 288 (202–334) 0.12 PT (%) 93 (83–99) 92 (80–101) 0.60 95 (88–101) 91 (81–99) 0.12 INR 1.09 (1.06–1.14) 1.09 (1.05–1.15) 0.74 1.07 (1.04–1.12) 1.1 (1.05–1.15) 0.48 aPTT (s) 23 (21–27) 25 (22–30) 0.43 23 (21–30) 24 (22–29) 0.49 D-dimer (ng/mL) 315 (164–1326) 263 (193–598) 0.22 277 (153–1,059) 263 (191–736) 0.52 Fibrinogen (mg/dL) 5 (4.5–5.7) 4.5 (3.3–5.3) 0.04 4.8 (4.5–5.4) 5.0 (3.8–5.4) 0.35 Antithrombin (%) 99 (91–111) 98 (86–104) 0.98 98 (85–104) 99 (90–111) 0.93 CRP (mg/L) 110 (55–167) 46 (16–96) < 0.001 93 (47–165) 64 (24–130) 0.12 PCT (ng/mL) 0.21 (0.1–0.99) 0.07 (0.04–0.13) <0.001 0.5 (0.07–1.1) 0.09 (0.04–0.16) < 0.01 Interleukin-6 (ug/mL) 63 (22–119) 49 (36–109) 0.56 85 (22–562) 43 (23–99) 0.38 Ferritin (ng/mL) 1,960 (1,250–2,498) 921 (610–1,315) < 0.001 1,683 (1,148–3,259) 994 (647–1,943) 0.01 Respiratory support O 2 -therapy 0 (0) 25 (78.1) < 0.001 – – – HFNC 0 (0) 5 (15.6) 0.06 – – – NIV 11 (34.4) 2 (6.3) 0.01 – – – IMV 21 (65.6) 0 (0) < 0.001 – – – Outcomes Symptomatic VTE 11 (34) 3 (9) 0.03 7 (33) 7 (16) 0.24 LOHS

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0040-1714350

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 252

Metadata

Authors
Spiezia, L., Boscolo, A., Correale, C., Sella, N., Pesenti, E., Beghetto, L., Campello, E., Poletto, F., Cerruti, L., Cola, M., De Cassai, A., Pasin, L., Eugenio, S., Vettor, R., Cattelan, A. M., Simioni, P., & Navalesi, P.
Venue
Thrombosis and Haemostasis
Published
2020-07-23
Volume
120
Issue
10
Pages
1474-1477
ISSN
  • 0340-6245 (ISSN-L)
  • 2567-689X
OpenAlex
W3045020713
Cited by
252
References
0
FWCI
7.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit. https://app.cochat.ai/papers/10.1055/s-0040-1714350
The paper
Spiezia, L., Boscolo, A., Correale, C., Sella, N., Pesenti, E., Beghetto, L., Campello, E., Poletto, F., Cerruti, L., Cola, M., De Cassai, A., Pasin, L., Eugenio, S., Vettor, R., Cattelan, A. M., Simioni, P., & Navalesi, P. (2020). Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0040-1714350

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.